Anna Lucsok - 24 Mar 2022 Form 4 Insider Report for ZYNEX INC (ZYXI)

Role
Chief Operating Officer - Zynex Medical, Inc.
Signature
/s/ Anna Lucsok
Issuer symbol
ZYXI
Transactions as of
24 Mar 2022
Net transactions value
$0
Form type
4
Filing time
25 Mar 2022, 16:01:43 UTC
Previous filing
28 Jan 2022
Next filing
29 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZYXI Common Stock (Restricted Stock Award) Award $0 +3,989 +5.2% $0.000000 80,727 24 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock award, issued pursuant to the Issuer's 2017 Stock Incentive Plan, pursuant to which 3,989 shares of the Issuer's common stock shall vest equally, on an quarterly basis, over a period of two years beginning one quarter from the grant date.
F2 Represents restricted stock awards under the Plan, which have not vested.

Remarks:

Chief Operating Officer - Zynex Medical, Inc.